SymBio Pharmaceuticals Limited (TYO:4582)
Japan flag Japan · Delayed Price · Currency is JPY
115.00
-6.00 (-4.96%)
Mar 9, 2026, 3:30 PM JST

SymBio Pharmaceuticals Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
7,3595,0249,12110,42125,39943,941
Upgrade
Market Cap Growth
-12.28%-44.92%-12.48%-58.97%-42.20%203.74%
Upgrade
Enterprise Value
6,4583,9003,9924,30619,26641,327
Upgrade
Last Close Price
115.0090.00199.00247.00643.001145.00
Upgrade
PE Ratio
----21.5421.62
Upgrade
PS Ratio
5.633.843.721.872.545.32
Upgrade
PB Ratio
5.783.952.171.452.996.51
Upgrade
P/TBV Ratio
5.783.952.171.453.076.77
Upgrade
P/FCF Ratio
----15.76383.47
Upgrade
P/OCF Ratio
----15.74313.77
Upgrade
EV/Sales Ratio
4.942.981.630.771.935.01
Upgrade
EV/EBITDA Ratio
----9.3437.23
Upgrade
EV/EBIT Ratio
----9.8140.68
Upgrade
EV/FCF Ratio
----11.95360.66
Upgrade
Debt / Equity Ratio
1.561.56----
Upgrade
Net Debt / Equity Ratio
-0.71-0.71-0.94-0.90-0.74-0.57
Upgrade
Net Debt / EBITDA Ratio
--1.059.13-3.04-3.48
Upgrade
Net Debt / FCF Ratio
0.200.201.1516.37-3.90-33.69
Upgrade
Asset Turnover
0.300.300.370.601.061.12
Upgrade
Inventory Turnover
1.371.372.463.365.643.69
Upgrade
Quick Ratio
2.442.445.737.774.353.96
Upgrade
Current Ratio
2.962.966.438.454.844.45
Upgrade
Return on Equity (ROE)
-174.65%-174.65%-67.22%-24.97%15.46%35.64%
Upgrade
Return on Assets (ROA)
-62.82%-62.82%-36.89%-5.46%13.00%8.62%
Upgrade
Return on Invested Capital (ROIC)
-987.08%-343.50%-838.27%-55.69%43.05%55.00%
Upgrade
Return on Capital Employed (ROCE)
-172.30%-172.30%-92.30%-11.30%23.10%14.70%
Upgrade
Earnings Yield
-64.91%-95.07%-42.02%-18.83%4.64%4.63%
Upgrade
FCF Yield
--91.08%-37.66%-3.82%6.35%0.26%
Upgrade
Buyback Yield / Dilution
-11.34%-11.34%-13.02%-0.75%-1.97%-17.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.